Amy Cheng

459 total citations
18 papers, 275 citations indexed

About

Amy Cheng is a scholar working on Molecular Biology, Pharmacology and Rheumatology. According to data from OpenAlex, Amy Cheng has authored 18 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Pharmacology and 3 papers in Rheumatology. Recurrent topics in Amy Cheng's work include Rheumatoid Arthritis Research and Therapies (3 papers), Computational Drug Discovery Methods (2 papers) and Autoimmune Bullous Skin Diseases (2 papers). Amy Cheng is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (3 papers), Computational Drug Discovery Methods (2 papers) and Autoimmune Bullous Skin Diseases (2 papers). Amy Cheng collaborates with scholars based in United States, China and Hong Kong. Amy Cheng's co-authors include Susan J. Bayliss, Sydney Tang, Loretta Y.Y. Chan, Hui Y. Lan, Kar Neng Lai, Joseph C.K. Leung, Yue Yu, W. Michael Dunne, Rustin D. Crutchley and Miao Lin and has published in prestigious journals such as PLoS ONE, Neurology and Annals of the Rheumatic Diseases.

In The Last Decade

Amy Cheng

16 papers receiving 265 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Cheng United States 10 53 50 43 41 36 18 275
Nuran Türkçapar Türkiye 13 62 1.2× 107 2.1× 33 0.8× 27 0.7× 19 0.5× 24 512
L. Mesci Türkiye 11 40 0.8× 31 0.6× 10 0.2× 17 0.4× 21 0.6× 20 350
Malgorzata Karawajczyk Sweden 11 43 0.8× 57 1.1× 13 0.3× 16 0.4× 3 0.1× 19 283
I. Messina Australia 6 116 2.2× 152 3.0× 14 0.3× 44 1.1× 15 0.4× 9 356
Satyaki Ganguly India 9 22 0.4× 37 0.7× 40 0.9× 77 1.9× 3 0.1× 58 282
Rida A. Frayha Lebanon 11 62 1.2× 22 0.4× 117 2.7× 62 1.5× 18 0.5× 28 333
Mary Bach United States 5 169 3.2× 113 2.3× 16 0.4× 21 0.5× 4 0.1× 6 358
George Mitroi Romania 9 42 0.8× 19 0.4× 13 0.3× 11 0.3× 3 0.1× 47 237
Erdinç Aydın Türkiye 15 48 0.9× 14 0.3× 35 0.8× 25 0.6× 7 0.2× 38 578
F. Kanoun Tunisia 9 55 1.0× 58 1.2× 10 0.2× 28 0.7× 5 0.1× 25 256

Countries citing papers authored by Amy Cheng

Since Specialization
Citations

This map shows the geographic impact of Amy Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Cheng more than expected).

Fields of papers citing papers by Amy Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Cheng. The network helps show where Amy Cheng may publish in the future.

Co-authorship network of co-authors of Amy Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Cheng. A scholar is included among the top collaborators of Amy Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Cheng. Amy Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Cheng, Amy. (2023). Understanding client descriptions of presenting problems :: formulating a taxonomy.. Scholarworks (University of Massachusetts Amherst).
2.
Masdeu, Joseph C., Belén Pascual, Paolo Zanotti‐Fregonara, et al.. (2020). [11C]MK-6884 PET Tracer for M4 Muscarinic Cholinergic Receptors in Alzheimer’s Disease: Comparison with [18F]FDG PET (2640). Neurology. 94(15_supplement). 4 indexed citations
3.
Lassman, Michael E., Derek L Chappell, Thomas McAvoy, et al.. (2020). Experimental Medicine Study to Measure Immune Checkpoint Receptors PD‐1 and GITR Turnover Rates In Vivo in Humans. Clinical Pharmacology & Therapeutics. 109(6). 1575–1582. 3 indexed citations
4.
Pascual, Belén, Paolo Zanotti‐Fregonara, Meixiang Yu, et al.. (2019). IC‐P‐142: [11C]MK‐6884 PET TRACER FOR M4 MUSCARINIC CHOLINERGIC RECEPTORS IN ALZHEIMER'S DISEASE: COMPARISON WITH [18F]FDG PET. Alzheimer s & Dementia. 15(7S_Part_2). 1 indexed citations
5.
Li, Wenping, Talakad G. Lohith, Guy Bormans, et al.. (2019). IC‐P‐150: [C‐11]MK‐6884 PET: CHARACTERIZING BRAIN M4 RECEPTORS IN HEALTHY ELDERLY VOLUNTEERS AND ACETYLCHOLINESTERASE INHIBITORS‐TREATED AD PATIENTS. Alzheimer s & Dementia. 15(7S_Part_2). 2 indexed citations
6.
Khalilieh, Sauzanne, Azher Hussain, Diana Montgomery, et al.. (2018). Effect of tildrakizumab (MK‐3222), a high affinity, selective anti‐IL23p19 monoclonal antibody, on cytochrome P450 metabolism in subjects with moderate to severe psoriasis. British Journal of Clinical Pharmacology. 84(10). 2292–2302. 28 indexed citations
7.
8.
Crutchley, Rustin D., et al.. (2016). Evaluating the role of atazanavir/cobicistat and darunavir/cobicistat fixed-dose combinations for the treatment of HIV-1 infection. HIV/AIDS - Research and Palliative Care. 8. 47–47. 11 indexed citations
9.
Beals, Chan, Richard Baumgartner, Charles Peterfy, et al.. (2013). SAT0492 Treatment Effects Measured by Dynamic Contrast Enhanced MRI and Ramris for Rheumatoid Arthritis. Annals of the Rheumatic Diseases. 72. A748–A748. 5 indexed citations
10.
Kelly, Stephen, Chan Beals, Marie‐Pierre Malice, et al.. (2012). Ultrasound of metacarpophalangeal joints is a sensitive and reliable endpoint for drug therapies in rheumatoid arthritis: results of a randomized, two-center placebo-controlled study. Arthritis Research & Therapy. 14(5). R198–R198. 17 indexed citations
11.
Bond, David J., et al.. (2011). Long-term efficacy of risperidone long-acting injectable in bipolar disorder with psychotic features. International Clinical Psychopharmacology. 26(3). 146–150. 10 indexed citations
12.
Tang, Sydney, Loretta Y.Y. Chan, Joseph C.K. Leung, et al.. (2011). Additive renoprotective effects of B2-kinin receptor blocker and PPAR-γ agonist in uninephrectomized db/db mice. Laboratory Investigation. 91(9). 1351–1362. 23 indexed citations
13.
Tang, Sydney, Loretta Y.Y. Chan, Joseph C.K. Leung, et al.. (2010). Differential effects of advanced glycation end‐products on renal tubular cell inflammation. Nephrology. 16(4). 417–425. 30 indexed citations
14.
Tang, Sydney, Joseph C.K. Leung, Loretta Y.Y. Chan, et al.. (2010). Renoprotection by Rosiglitazone in Accelerated Type 2 Diabetic Nephropathy: Role of STAT1 Inhibition and Nephrin Restoration. American Journal of Nephrology. 32(2). 145–155. 24 indexed citations
15.
Cheng, Amy & Susan J. Bayliss. (2008). The genetics of hair shaft disorders. Journal of the American Academy of Dermatology. 59(1). 1–22. 31 indexed citations
16.
Yu, Yue, et al.. (2007). Hot tub folliculitis or hot hand–foot syndrome caused by Pseudomonas aeruginosa. Journal of the American Academy of Dermatology. 57(4). 596–600. 39 indexed citations
17.
Cheng, Amy. (2006). Oral Erosive Lichen Planus Treated With Efalizumab. Archives of Dermatology. 142(6). 680–680. 40 indexed citations
18.
Cheng, Amy. (2005). Narratives of second -generation Asian American experience: Legacies of immigration, trauma, and loss. ScholarWorks@UMassAmherst (University of Massachusetts Amherst).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nuran Türkçapar Breakdown of academic impact, for papers by L. Mesci Breakdown of academic impact, for papers by Malgorzata Karawajczyk Breakdown of academic impact, for papers by I. Messina Breakdown of academic impact, for papers by Satyaki Ganguly Breakdown of academic impact, for papers by Rida A. Frayha Breakdown of academic impact, for papers by Mary Bach Breakdown of academic impact, for papers by George Mitroi Breakdown of academic impact, for papers by Erdinç Aydın Breakdown of academic impact, for papers by F. Kanoun
Rankless by CCL
2026